TABLE 1.
Clinical and biochemical characteristics of study subjects.
| Characteristic | Diabetic Participants with Hypertriglyceridemia (n=45) Group 1 |
Diabetic Participants without Hypertriglyceridemia (n=26) Group 2 |
P |
|---|---|---|---|
| Demographic profile | |||
| Sex | 22 males, 23 females | 13 males, 13 females | 0.92 |
| Age (years) | 59 ± 11 | 58 ± 12 | 0.71 |
| Body mass index (kg/m2) | 35 ± 8 | 35 ± 10 | 0.74 |
| Waist Circumference (cm) | 118 ± 18 | 110 ± 16 | 0.09 |
| Vital signs | |||
| Systolic blood pressure (mm Hg) | 129 ± 15 | 131 ± 19 | 0.67 |
| Diastolic blood pressure (mm Hg) | 76 ± 8 | 77 ± 11 | 0.57 |
| Medications | |||
| Aspirin (%) | 31 | 53 | 0.06 |
| Statin (%) | 48 | 15 | 0.05 |
| Metformin (%) | 37 | 46 | 0.12 |
| Insulin (%) | 24 | 34 | 0.37 |
| Beta blocker (%) | 6 | 3 | 0.62 |
| ACE inhibitors or ARBs (%) | 35 | 38 | 0.82 |
| Ca channel blockers (%) | 1 | 0.07 | 0.64 |
| Niacin (%) | 0.08 | 0 | 0.12 |
| Fibrates (%) | 11 | 0 | 0.12 |
| Fish oil (%) | 0.04 | 0 | 0.1 |
Data are means ± SD
1
: Median Fluorescence Intensity